Test cancer patients for clot susceptibility, group recommends

06/5/2013 | MedPage Today (free registration)

Cancer patients should be regularly tested for thromboembolic risk upon starting chemotherapy, according to guidelines from the American Society of Clinical Oncology that are published in the Journal of Clinical Oncology. The group recommended low-molecular-weight heparin for prophylaxis. Newer oral anticoagulants should not be administered in patients with malignancy.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC